Related Experiment Video

Updated: Aug 16, 2026

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.3K

N,N-Dimethylglycine in patients with progressive multiple sclerosis: result of a pilot double-blind, placebo,

Thomas Wolfsegger1, Klaus Böck2, Wolfgang Schimetta3

  • 1Department of Neurology 1, Kepler University Hospital, Neuromed Campus, Wagner-Jauregg-Weg 15, 4020, Linz, Austria. thomas.wolfsegger@kepleruniklinikum.at.

Neurological Research and Practice
|May 24, 2021
PubMed

Keywords:
Dietary supplementMobilityMultiple sclerosisN,N-DimethylglycineNutrition therapy

More Related Videos

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

4.3K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.7K

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...